Biomodics ApS
Private limited companyCVR 32887082Kgs.LyngbyActive
Biomodics ApS is a private limited company, based in Kgs.Lyngby, active in research and experimental development on natural sciences and engineering, founded in 2010. Net profit rose 404% from 2024 to 2025, ending at DKK 2.4m. Profit has grown three years in a row. Equity grew to DKK 5.9m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 58% (2024 → 2025), to DKK 5.9m.
- Net profit rose 404% (2024 → 2025), to DKK 2.4m.
- Equity rose 69% (2024 → 2025), to DKK 5.9m.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 1,916 | 1,253 | 4,349 | 2,809 | 3,738 | 5,889 | +57.6% |
| Operating profit (EBIT) | −481 | −672 | 1,999 | 257 | 614 | 3,108 | +406.5% |
| Profit before tax | −487 | −701 | 1,952 | 293 | 619 | 3,121 | +403.8% |
| Net profit | −461 | −680 | 1,675 | 392 | 482 | 2,430 | +404.5% |
| Total assets | 2,741 | 2,985 | 8,064 | 6,684 | 7,091 | 10,119 | +42.7% |
| Equity | 1,638 | 958 | 2,633 | 3,025 | 3,507 | 5,937 | +69.3% |
| Liabilities | 1,102 | 2,027 | 5,419 | 3,649 | 3,584 | 4,172 | +16.4% |
| Cash and cash equivalents | 974 | 656 | 3,440 | 3,464 | 4,344 | 4,121 | −5.1% |
| Average number of employees | 3 | – | 3 | – | – | 3 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 28/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 18/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 29/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 08/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 29/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 29/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 10,959of 69,742 Better than 84% | No. 12,680of 69,964 Better than 82% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 41of 323 Better than 88% | No. 86of 329 Better than 74% |
| Companies that are between 15 and 29 years old24,910 companies in the comparison | No. 8,758of 24,791 Better than 65% | No. 8,901of 24,909 Better than 64% |
| All companies of type ApS66,508 companies in the comparison | No. 11,583of 66,379 Better than 83% | No. 9,958of 66,505 Better than 85% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Biomodics ApSDKK 5.9m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Biomodics ApSDKK 2.4m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Biomodics ApSDKK 5.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Biomodics ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Ptt Holding ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Peter Thomsen | Director | 28/04/2010 |
- Auditor
- Revisionsfirmaet Poul Rexen Thomsen ApS
- Founders
- Peter Thomsen
Signing rule: Selskabet ledes af en direktør, som tegner selskabet.
Address and production units
2 active production unitsStengårds Alle 31A
2800 Kgs.Lyngby
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Biomodics ApS | Fjeldhammervej 15, 2610 Rødovre | 4 | 1023420038 |
| BIOMODICS ApS | Stengårds Alle 31A, 2800 Kgs.Lyngby | 1 | 1016017791 |
Purpose
Selskabets formål er at forske og udvikle løsninger og produkter til sundhedssektoren, samt hermed beslægtet virksomhed
The purpose is quoted from the register in Danish.
Changes year by year
11 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20104 changesindustry 1 · founded 1 · management 1 · ownership 1
- IndustryIndustry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
- FoundedRegistered as BIOMODICS ApS
- ManagementPeter Thomsen appointed director
- OwnershipPTT HOLDING ApS registered as owner (100%)
Related companies
Same industry in Lyngby-Taarbæk
- Thales Aerospace Communications Lyngby ApS52 employees
- Immudex ApS35 employees
- Capres A/S34 employees
- Novo Nordisk Foundation Cellerator A/S33 employees
- Mdsi ApS33 employees
- Bifrost Communications ApS9 employees
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.